Haoxi Health Technology (HAO) Current Deferred Revenue (2023 - 2025)

Haoxi Health Technology's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 68.96% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $1.2 million (up 68.96% YoY), while the FY2025 annual figure was $537646.0, down 54.63% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $1.2 million, up from $537646.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.5 million in Q2 2023, with the low at $537646.0 in Q2 2025.
• The 3-year median for Current Deferred Revenue is $1.2 million (2024), against an average of $1.0 million.
• Peak annual rise in Current Deferred Revenue reached 68.96% in 2025, while the deepest fall reached 54.63% in 2025.
• Haoxi Health Technology's Current Deferred Revenue stood at $1.5 million in 2023, then plunged by 51.5% to $724551.0 in 2024, then surged by 68.96% to $1.2 million in 2025.
• Business Quant data shows HAO's Current Deferred Revenue at $1.2 million in Q4 2025, $537646.0 in Q2 2025, and $724551.0 in Q4 2024.